Investing
256 Articles
The jobs situation may have been weak enough to spur Fed action. (Reuters) As Facebook Inc. (NASDAQ: FB) shares fall,…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday…
GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment…
Warren Buffett of Berkshire Hathaway Inc. (NYSE: BRK-A) (NYSE: BRK-B) is often considered the greatest investor in modern times. Some…
Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…
The three major US stock indexes opened lower this morning following some lackluster data on the US economy. The Empire…
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to…
Updated throughout the day on the 24/7 Wall St. Wire: GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI)…
Much of the financial future of Europe is still caught in a web of the political movements of Germany’s Angela…
GlaxoSmithKline (NYSE: GSK) will take over Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters) A poll from the National Association…
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks…
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released their most recent U.S.-listed equity holdings for the…
Coalition talks in Greece are unlikely to create a new government, raising the chance Greece could leave the eurozone. (Reuters)…
A judge objects to parts of an AIG (NYSE: AIG) suit to block a Bank of America (NYSE: BAC) settlement…
Our top personal finance-related articles today. Your wallet will thank you later.